作为TGR5激动剂的Leoligin灵感合成利格南的识别和表征
Alexander F Perhal1, Patrik F Schwarz1, Thomas Linder2
1Department of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
Journal of natural products
|March 27, 2025
概括
研究人员将LT-188A确定为一种新的TGR5激动剂. 这种化合物通过减少巨细胞中的促炎细胞因子和氧化来表现出抗炎作用,为治疗炎症性疾病提供了潜在的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- G蛋白结合胆酸受体1 (GPBAR1或TGR5) 调节新陈代谢和免疫功能.
- 对TGR5的药理向可以缓解2型糖尿病和动脉样硬化等炎症状况.
- 莱奥利金及其类似物表现出抗炎作用,但其分子点仍然不清楚.
研究的目的:
- 为了确定抗炎化合物的新分子标.
- 为了研究莱奥利金类同类药物的作用机制.
- 描述LT-188A作为一种潜在的TGR5激动剂和抗炎剂.
主要方法:
- 合成LT-188A,这是一个结构类比的莱奥利金.
- 对周期性腺单酸盐 (cAMP) 积累和CRE-依赖的光酶活性进行检测.
- 在TGR5表达细胞中抑制核因子 κB (NFκB) 激活.
- 定量PCR (qPCR) 和格里斯试验用于测量巨细胞中的促炎性细胞因子和氧化 (NO) 水平.
主要成果:
- LT-188A表现为TGR5激素,诱导cAMP以TGR5依赖的方式积累.
- 特别是在TGR5表达细胞中,LT-188A抑制了NFκB的激活.
- 在巨细胞中,LT-188A降低了促炎性细胞因子表达和NO的产生.
结论:
- LT-188A是一种新的,非类固醇的TGR5激动剂,灵感来自天然产品.
- 在相关细胞模型中,LT-188A在体外表现出显著的抗炎活性.
- LT-188A代表了一种有前途的工具化合物,用于进一步开发治疗炎症疾病.
相关概念视频
Cell Signaling in Plants
5.6K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.6K
G Protein-coupled Receptors
11.0K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.0K
Glucagon-like Receptor Agonists
277
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
277
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


